PIWI‐interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
Neuroblastoma (NB) is the leading pediatric cancer known for its heterogeneity and clinical
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …
PIWI-interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells
J Roy, B Das, N Jain, B Mallick - Journal of cellular …, 2020 - pubmed.ncbi.nlm.nih.gov
Neuroblastoma (NB) is the leading pediatric cancer known for its heterogeneity and clinical
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …
PIWI-interacting RNA 39980 promotes tumor progression and reduces drug sensitivity in neuroblastoma cells.
J Roy, B Das, N Jain, B Mallick - Journal of Cellular Physiology, 2019 - europepmc.org
Neuroblastoma (NB) is the leading pediatric cancer known for its heterogeneity and clinical
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …
aggressiveness leading to chemoresistance. Recent evidence in small RNA research has …